Breast Cancer

Top Story

City of Hope names director of pharmaceutical initiatives

October 21, 2017

George Somlo, M D, has been appointed director of pharmaceutical initiatives at City of Hope.

Somlo, recognized for his research related to breast cancer and hematology, serves as professor with joint appointments in the departments of medical oncology/therapeutics research and hematology/hematopoietic cell transplantation. He also serves as president of City of Hope’s medical staff and a member of its board of directors.

Meeting News

Cancer survivor: Clinicians can help patients through emotional support, meaningful communication

October 19, 2017
NASHVILLE, Tenn. — Members of the cancer care team can greatly help their patients by striving to reduce the overwhelming nature of their diagnosis, offering…
In the Journals Plus

Fewer newly diagnosed patients with cancer lack insurance after ACA

October 19, 2017
Uninsurance rates among patients newly diagnosed with cancer dropped one-third during the Affordable Care Act’s first year of implementation, according to study…
FDA News

FDA grants fast track designation to elacestrant for breast cancer subtype

October 18, 2017
The FDA granted fast track designation to elacestrant for the treatment of ER-positive, HER-2-negative advanced or metastatic breast cancer, according to the…
More Headlines »
CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Video
Meeting News

VIDEO: Neratinib, capecitabine demonstrate ‘impressive’ results in metastatic breast cancer

September 7, 2017
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

Advertisement
Advertisement